Alogliptin Benzoate Reagent Market In Global
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective f ... Read More
Alogliptin Benzoate is one DPP-4 inhibitor which can be used to slow the inactivation of incretin hormones GLP-1 and GIP.
This report contains market size and forecasts of Alogliptin Benzoate API in global, including the following market information:
Global Alogliptin Benzoate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alogliptin Benzoate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Alogliptin Benzoate API companies in 2021 (%)
The global Alogliptin Benzoate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alogliptin Benzoate API include Metrochem API, Hecpharm, Angle Bio Pharma, Jigs chemical, Yihe-Chem, Dasheng Pharmaceutical Tech, Tecoland, CAD Pharma and Hefei Home Sunshine Pharmaceutical Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alogliptin Benzoate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alogliptin Benzoate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alogliptin Benzoate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Alogliptin Benzoate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alogliptin Benzoate API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Alogliptin Benzoate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Alogliptin Benzoate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alogliptin Benzoate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alogliptin Benzoate API revenues share in global market, 2021 (%)
Key companies Alogliptin Benzoate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Alogliptin Benzoate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Metrochem API
Hecpharm
Angle Bio Pharma
Jigs chemical
Yihe-Chem
Dasheng Pharmaceutical Tech
Tecoland
CAD Pharma
Hefei Home Sunshine Pharmaceutical Technology
Hangzhou Dragonpharm
Sinoway Industrial
Wisdom Pharmaceutical
MuseChem
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective f ... Read More
Azilsartan medoxomil is in a group of drugs called angiotensin II receptor antagonists. Azilsarta ... Read More
Azilsartan medoxomil is a prodrug form of azilsartan, a potent and selective angiotensin II recep ... Read More
Bromocriptine, an ergoline derivative, is a dopamine agonist that is used in the treatment of pit ... Read More